Anti-cancer drug reverses Alzheimer’s disease deficits in mice

The research examined previously published studies on the drug bexarotene, which is approved by the U.S. FDA for the treatment of cutaneous T cell lymphoma.

Anti-cancer drug reverses Alzheimer’s disease deficits in mice

Science Recorder | James Fluere | Saturday, May 25, 2013

Researchers from the University of Pittsburgh Graduate School of Public Health have discovered that an anti-cancer drug reverses Alzheimer's disease deficits in mice. The researchers examined previously published studies on the drug bexarotene, which is approved by the FDA for the treatment of cutaneous T cell lymphoma... To continue reading, subscribe to Science Recorder today.

Subscribe Today
Subscribe to Science Recorder and gain access to one of the web's largest collection of science news and analysis.
 
Login
 


Did we miss something? Send us tips, press releases, or ideas for stories: tips@sciencerecorder.com